NHS may not be able to replace Palantir before £330m deal deadline

The National Health Service (NHS) faces a critical deadline regarding its £330 million contract with data analytics firm Palantir, with the potential to replace the platform uncertain. This deadline has intensified pressure on UK ministers to sever ties with the US tech company. With over 44,000 individuals submitting formal objections, citing concerns over the processing of their data through Palantir's platform, the situation has become increasingly contentious.

Palantir has countered these claims, highlighting its use of open-source frameworks, such as Python and Apache Spark, and emphasizing interoperability as a core design principle. However, the government acknowledges the practical challenges in replacing the existing system, the Facility Design Platform (FDP), before March. In a letter to the Health and Social Care Committee, Health Minister James Frith expressed uncertainty over the continuity and reliability of the service, stating that a new contract might not be available by the specified deadline.

Palantir's response to criticism over its performance emphasizes the government's reported benefits, including an estimated £808 million in value and a return of £4.92 for every £1 invested. They also cite improvements such as a 14.3% increase in operations, a 14.3% reduction in discharge delays for long-stay patients, and a 5.8% average improvement in meeting the NHS's 28-day Faster Cancer Diagnosis Standard.

Notably, 44,000 individuals have utilized their data protection rights to object to their information being processed through Palantir's platform, yet the company maintains that it only acts as a data processor, with NHS bodies retaining control over how the data is utilized and for how long.